Nitric oxide metabolites are associated with survival in older patients

Journal of the American Geriatrics Society

Volumn 55, Issue 9, 2007, Pages 1398-1403

  Hayashi, Toshio ^a   Nomura, Hideki ^a   Osawa, Masako ^a   Funami, Jun ^a   Miyazaki, Asaka ^a   Iguchi, Akihisa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Albumin; Biomarker; cGMP; Comprehensive geriatric assessment; Elderly; Nitric oxide

Indexed keywords

ALBUMIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CHEMICAL ANALYSIS; COGNITIVE DEFECT; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION DISORDERS; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; JAPAN; MALE; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548287908     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01296.x     Document Type: Article

References (30)

1. Reuben DB, Greendale GA, Harrison GC. Nutritional screening in older persons. J Am Geriatr Soc 1995 43 : 415 425.
2. Reuben DB, Ix JH, Greendale GA et al. The predictive value of combined hypoalbuminemia and hypercholesterolemia in high functioning community-dwelling older persons: MacArthur studies of successful aging. J Am Geriatr Soc 1999 47 : 402 406.
3. Ferrari R, Bachtti T, Confortini R et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995 92 : 1479 1486.
4. Finkel MS, Odds CV, Jacob TD et al. Negative ionotropic effect of cytokines on the heart mediated by nitric oxide. Science 1992 257 : 387 389.
5. Wiedermann CJ, Beimpold H, Herold M et al. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 1993 22 : 1897 1901.
6. Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999 106 : 506 512.
7. Ferrucci L, Harris RB, Guralnik JM et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999 47 : 639 646.
8. Stessman J, Hammerman-Rozenberg R, Maaravi Y et al. Strategies to enhance longevity and independent function: The Jerusalem Longitudinal Study. Mech Ageing Dev 2005 126 : 327 331.
9. Mukoyama M, Nakao K, Saito N et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990 323 : 757 758.
10. Chinkers M, Garbers DL, Chang MS et al. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989 338 : 78 83.
11. Palmer RMJ, Ferrige AG, Moncada S et al. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987 327 : 524 526.
12. Nomura H, Hayashi T, Esaki T et al. Standardization of plasma brain natriuretic peptide concentration in elderly Japanese - relation to latent dysfunction and ischemic heart disease. J Am Geriatr Soc 2002 50 : 1504 1509.
13. Hayashi T, Esaki T, Muto E et al. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: The possible role of nitric oxide. Arterioscler Thromb Vasc Biol 2000 20 : 782 792.
14. Okano K, Takahashi S, Yasuda K et al. Using microparticle labeling and counting for attomole-level detection in heterogeneous immunoassay. Anal Biochem 1992 202 : 120 125.
15. Mancia G, Grassi G. European society of hypertension. European Society of Cardiology. Joint National Committee VII and European Society of Hypertension/European Society of Cardiology guidelines for evaluating and treating hypertension: A two-way road? J Am Soc Nephrol 2005 16 (Suppl 1) : S74 S77.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
17. Cui Y, Blumenthal RS, Flaws JA et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001 16 : 1413 1419.
18. Resnick HE, Harris MI, Brock DB et al. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: Results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000 23 : 176 180.
19. Mahoney F, Barthel DW. Functional evaluation. The Barthel Index. Md State Med J 1965 14 : 61 65.
20. Tsutsui T, Muramatsu N. Care-needs certification in the long-term care insurance system of Japan. J Am Geriatr Soc 2005 53 : 522 527.
21. Reuben DB, Cheb AI, Harris TB et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002 50 : 638 644.
22. Gardner RS, Chong V, Morton I et al. N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and tumor necrosis factor-a in patients referred for consideration of cardiac transplantation. Eur J Heart Fail 2005 7 : 253 260.
23. Hayashi T, Ishikawa T, Naito M et al. Low level hyperlipidemia impairs endothelium-dependent relaxation of porcine coronary arteries by two mechanisms. Functional change in endothelium and impairment of endothelium-dependent relaxation by two mediators. Atherosclerosis 1991 87 : 23 38.
24. Hayashi T, Sumi D, Juliet PA et al. Gene transfer of endothelial NO synthase, but not eNOS, plus inducible NOS regressed atherosclerosis in rabbits. Cardiovasc Res 2004 61 : 339 351.
25. Ignarro LJ, Napoli C. Novel feature of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep 2004 6 : 281 287.
26. Ignarro LJ, Buga GM, Wei LH et al. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001 98 : 4202 4208.
27. Habib F, Dutka D, Crossman D et al. Enhanced basal nitric oxide production in heart failure: Another failed counter-regulatory vasodilator mechanism? Lancet 1994 344 : 371 373.
28. Garbers DL, Lowe DG. Guanylyl cyclase receptors. J Biol Chem 1994 267 : 307 414.
29. Agnletti L, Curello S, Bachetti T et al. Serum from patients with severe heart failure downregulates enos and is proapoptotic: Role of tumor necrosis factor-alpha. Circulation 1999 100 : 1983 1991.
30. Auch-Schwelk W, Kuchenbuch C, Claus M et al. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors. Eur Heart J 1993 14 (Suppl I) : 154 160.